Inventurus Knowledge Solutions Stock Price : Shares of Inventurus Knowledge Solutions Limited, an investment company of veteran investor Rekha Jhunjhunwala, have entered the stock market with strength today. The company’s shares were listed on BSE at Rs 1856, while the IPO price was Rs 1329. In this sense, investors have got 40 percent listing gain in this. The size of the IPO was Rs 2498 crore, while it received bids of about 53 times the issue size i.e. Rs 72,574.26 crore. Brokerage houses are also positive on the company’s outlook. The company provides healthcare help services.
IPO Alert! Keep money ready in bank account, 8 IPOs are opening on 19th and 20th December, golden opportunity to earn.
Inventurus Knowledge: Investors gave strong response
The IPO of Inventurus Knowledge Solutions Limited was subscribed 52.68 times overall. 75 percent of the IPO was reserved for qualified institutional investors and it was filled 80.64 times. In this, 15 percent share was reserved for non-institutional buyers and it was filled 23.25 times. Whereas 10 percent share was reserved for retail investors and it was filled 14.55 times.
Swastika Investmart on Company
Brokerage house Swastika Investmart says Inventurus Knowledge has demonstrated good financial performance with improvement in growth and margins. The company is a leading partner in outpatient and inpatient care with no listed peers.
MobiKwik Listing Gains: MobiKwik shares made investors happy, gave 59% return as soon as it debuted in the market, should one book profits?
Mehta Equities on the company
Brokerage house Mehta Equities says the company’s expertise in integrating solutions in revenue optimization, clinical support, digital health and EHR migration has made it a preferred partner in the healthcare ecosystem. Following the acquisition of Equity Holdings, the company expanded its customer base from 45 in FY2022 to 778 by September 2024, reflecting strong growth and synergy.
Vishal Mega Mart Listing Gains: Vishal Mega Mart shares gave 41% return on listing, should we book profits or wait for more profits?
Deven Choksi Research on Company
Deven Choksi Research says the company holds a leadership position in healthcare operations and analytics with a focus on revenue cycle management (RCM), telehealth and clinical data optimization. The company leverages proprietary technologies to provide scalable, cost-efficient and high-impact solutions.
The company has strong client relationships, with more than 98 per cent of its revenue coming from repeat customers, underpinned by its ‘Land and Expand’ strategy. The growth trajectory of the US healthcare market, coupled with the increasing reliance on outsourced services, provides significant expansion potential for the company.
(Disclaimer: The view or advice on the share is given by the brokerage house. These are not the personal views of Financial Express. There are risks in the market, so take expert opinion before investing.)
